Edition:
United States

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

8.66USD
14 Dec 2018
Change (% chg)

$0.01 (+0.12%)
Prev Close
$8.65
Open
$8.58
Day's High
$8.89
Day's Low
$8.52
Volume
145,917
Avg. Vol
166,575
52-wk High
$15.59
52-wk Low
$7.39

Chart for

About

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)

Overall

Beta: 1.86
Market Cap(Mil.): $517.71
Shares Outstanding(Mil.): 59.44
Dividend: --
Yield (%): --

Financials

  CBAY.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.04 -- --
ROI: -41.47 0.60 13.80
ROE: -42.34 -2.18 15.29

Earnings vs. Estimates